The Theranos Lab controversy strikes again. This time, the med-tech startup was informed by the Centers for Medicare and Medicaid Services (CMS) that it must...
Theranos Lab is back in the news cycle. And from the sounds of the reports, the controversy won’t be going away anytime soon. What’s been relayed so...
Just as the public equity markets began 2016 with a serious rout, now comes the news that unicorns are falling out of good graces with...
The movement to grab fundraising among technology startups last year found strong support among private equity players, but that reception might be a little stonier...
If 2015 was the year of the unicorn, 2016 may be the year the wings come off the horse. Here’s why private firms may stay...